Translational Inefficiencies in Traumatic Brain Injury Research: Evidence From 94 399 Publications

Despite extensive investigation, no proven neuroprotective therapy exists for traumatic brain injury. Although this translational gap has been widely discussed, it has not been objectively characterized through systematic analysis. We hypothesized that this deficit reflects not only biological intractability but also constraints within the research ecosystem that impede translational progress.

Web of Science, PubMed, and Scopus were searched without date or document type restrictions. A natural language processing pipeline screened results and classified study designs, topical areas, geographic affiliations, and funding sources. All analyses and visualizations were performed using open-source Python libraries.

94 399 publications spanning 1829 to 2026 comprised the corpus. Research output was geographically concentrated. Thematic network analysis revealed 4 discrete research domains (preclinical, acute clinical, chronic/rehabilitation, and sports-related), with the preclinical domain spatially isolated from all 3 clinical clusters. Randomized controlled trials comprised 1.5% of publications, while reviews exceeded 20% of annual output throughout the 21st century. Preclinical research share peaked near 23% of annual publications around 2000 and subsequently declined without a commensurate rise in clinical trial activity (Chow test, P < .001). Diagnostic biomarker research comprised 3.8% of publications but remained poorly integrated with prospective trial designs. Postacute pharmacotherapy research represented 0.8% of publications and the smallest trial-integrated fraction of any area examined. Citation concentration was substantial (Gini 0.725), with nearly one-fifth of publications uncited. Journal-level analysis revealed a sustained decline in neurosurgery-specific journal representation from 1980 to 2025; in 1993, neurology and neuroscience journals surpassed neurosurgery journals in proportional share of annual publications and have maintained that lead since. National Institutes of Health-funded research, the largest funder by a factor of 5, produced randomized controlled trial rates indistinguishable from those of unfunded literature (1.6%).

Traumatic brain injury literature has grown substantially without commensurate advances in high-evidence research, reflecting identifiable inefficiencies in infrastructure and funding strategy that represent targets for intervention.